In NSCLC and gastric cancer, METTL3 promoted migration through downstream activation of PI3K/AKT; however, whether this mechanism is m6A-dependent is unclear (Lin S. et al., 2019; Wei et al., 2019). The gene discussed is METTL3; the disease is gastric cancer.